Damora Therapeutics (DMRA) Net Income towards Common Stockholders (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.89% |
| Dec 31, 2025 | -6,183.95% |
| Sep 30, 2025 | 8.84% |
| Jun 30, 2025 | -35.69% |
| Mar 31, 2025 | -155.02% |
| Dec 31, 2024 | 218.57% |
| Sep 30, 2024 | 27.26% |
| Jun 30, 2024 | 2.54% |
| Mar 31, 2024 | 15.41% |
| Dec 31, 2023 | 20.42% |
| Sep 30, 2023 | 24.27% |
| Jun 30, 2023 | 20.37% |
| Mar 31, 2023 | 0.24% |
| Dec 31, 2022 | 0.71% |
| Sep 30, 2022 | 20.44% |
| Jun 30, 2022 | -1.07% |
| Mar 31, 2022 | -25.77% |
| Dec 31, 2021 | -6.08% |
| Sep 30, 2021 | -3.49% |
| Jun 30, 2021 | 9.47% |
| Mar 31, 2021 | -244.92% |
| Dec 31, 2020 | 72.65% |
| Sep 30, 2020 | -126.63% |
| Jun 30, 2020 | -8.71% |
| Mar 31, 2020 | 77.42% |
| Dec 31, 2019 | -369.02% |